Neal Pawar - Nov 27, 2023 Form 4 Insider Report for Enfusion, Inc. (ENFN)

Role
Chief Operating Officer
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Stock symbol
ENFN
Transactions as of
Nov 27, 2023
Transactions value $
-$249,950
Form type
4
Date filed
11/29/2023, 07:04 PM
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +580K $0.00 580K Nov 27, 2023 Direct F1
transaction ENFN Class A Common Stock Award $0 +425K +73.28% $0.00 1.01M Nov 27, 2023 Direct F2
transaction ENFN Class A Common Stock Award $0 +60.7K +6.04% $0.00 1.07M Nov 27, 2023 Direct F3
transaction ENFN Class A Common Stock Tax liability -$250K -25.3K -2.37% $9.89 1.04M Nov 27, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan (the "Plan"). 100,000 and 120,000 of the RSUs will vest if certain performance milestones are achieved on or prior to November 27, 2026, and 160,000 and 200,000 of the RSUS will vest if additional performance milestones are achieved on or prior to November 27, 2028.
F2 Consists of RSUs awarded pursuant to the Plan. The RSUs will vest in full as follows: 141,667, 141,667 and 141,666 on each of November 27, 2024, 2025, and 2026.
F3 Consists of fully vested shares issued under the Plan (the "Vested Shares").
F4 Consists of shares withheld to satisfy tax withholding obligations resulting from delivery of the Vested Shares to the reporting person; not an open market transaction